250PA global phase III clinical study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients. (18th September 2017) - Saeki, T.; Mukai, H.; Ro, J.; Lin, Y-C.; Fujiwara, Y.; Nagai, S.; Lee, K.S.; Watanabe, J.; Ohtani, S.; Kim, S.B.; Kuroi, K.; Tsugawa, K.; et al.